Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N
Clin Exp Immunol. 2001; 124(3):392-7.
PMID: 11472399
PMC: 1906081.
DOI: 10.1046/j.1365-2249.2001.01571.x.
Pereira R, Simon M, Simmons A
J Virol. 2000; 74(2):1029-32.
PMID: 10623769
PMC: 111627.
DOI: 10.1128/jvi.74.2.1029-1032.2000.
Kos F
Immunol Res. 1998; 17(3):303-12.
PMID: 9638474
DOI: 10.1007/BF02786453.
Smyth M, Trapani J
J Virol. 1998; 72(1):1-9.
PMID: 9420194
PMC: 109343.
DOI: 10.1128/JVI.72.1.1-9.1998.
Mullbacher A, Ebnet K, Blanden R, Hla R, Stehle T, MUSETEANU C
Proc Natl Acad Sci U S A. 1996; 93(12):5783-7.
PMID: 8650169
PMC: 39138.
DOI: 10.1073/pnas.93.12.5783.
Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
Vaz F, Silva M, Ascensao J
Br J Cancer. 1995; 72(6):1498-503.
PMID: 8519666
PMC: 2034089.
DOI: 10.1038/bjc.1995.536.
The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.
Kulkarni A, Connors M, Firestone C, Morse 3rd H, Murphy B
J Virol. 1993; 67(2):1044-9.
PMID: 8419638
PMC: 237459.
DOI: 10.1128/JVI.67.2.1044-1049.1993.
In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.
Arora D, Houde M, Justewicz D, Mandeville R
J Virol. 1984; 52(3):839-45.
PMID: 6387178
PMC: 254604.
DOI: 10.1128/JVI.52.3.839-845.1984.
Lysis of uninfected and virus-infected cells in vivo: a rejection mechanism in addition to that mediated by natural killer cells.
Biron C, Habu S, Okumura K, Welsh R
J Virol. 1984; 50(3):698-707.
PMID: 6374165
PMC: 255727.
DOI: 10.1128/JVI.50.3.698-707.1984.
The role of cellular susceptibility in the declining severity of respiratory influenza of ferrets with age.
COATES D, Husseini R, Collie M, Sweet C, Smith H
Br J Exp Pathol. 1984; 65(1):29-39.
PMID: 6365145
PMC: 2040949.
Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.
Sakuma T, Suenaga T, Yoshida I, Azuma M
Infect Immun. 1983; 42(2):567-73.
PMID: 6315580
PMC: 264465.
DOI: 10.1128/iai.42.2.567-573.1983.
Natural killer cell activity in renal transplant recipients receiving cyclosporine.
Gui X, Rinaldo Jr C, Ho M
Infect Immun. 1983; 41(3):965-70.
PMID: 6309674
PMC: 264595.
DOI: 10.1128/iai.41.3.965-970.1983.
X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production.
Pedersen E, Haahr S, Mogensen S
Infect Immun. 1983; 42(2):740-6.
PMID: 6196293
PMC: 264492.
DOI: 10.1128/iai.42.2.740-746.1983.
Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
Bishop G, Glorioso J, Schwartz S
J Exp Med. 1983; 157(5):1544-61.
PMID: 6189940
PMC: 2187020.
DOI: 10.1084/jem.157.5.1544.
Natural killer cells in resistance to virus-infected cells.
Rager-Zisman B, Bloom B
Springer Semin Immunopathol. 1982; 4(4):397-414.
PMID: 6183763
DOI: 10.1007/BF02053741.
Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
Hidore M, Murphy J
Infect Immun. 1986; 51(2):547-55.
PMID: 3510981
PMC: 262374.
DOI: 10.1128/iai.51.2.547-555.1986.
Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
McIntyre K, Welsh R
J Exp Med. 1986; 164(5):1667-81.
PMID: 3490535
PMC: 2188440.
DOI: 10.1084/jem.164.5.1667.
Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.
Heidemann E, Weber J, Schmidt H, Reichmann U
Klin Wochenschr. 1986; 64(20):1036-40.
PMID: 3465970
DOI: 10.1007/BF01757211.
Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.
Hussain M, Alviggi L, Millward B, Leslie R, Pyke D, Vergani D
Diabetologia. 1987; 30(12):907-11.
PMID: 3436487
DOI: 10.1007/BF00295872.
Dendritic cells that have interacted with antigen are targets for natural killer cells.
Shah P, Gilbertson S, Rowley D
J Exp Med. 1985; 162(2):625-36.
PMID: 3160806
PMC: 2187744.
DOI: 10.1084/jem.162.2.625.
